India to Afghanistan: Sorafenib Export Trade Route
India has recorded 19 verified shipments of Sorafenib exported to Afghanistan, representing a combined trade value of $174.7K USD. This corridor is served by 8 active Indian exporters, with an average shipment value of $9.2K USD. The leading Indian exporter is MEDYRA PHARMACEUTICAL, which accounts for 80% of total export value with 6 shipments worth $139.4K USD. On the buying side, BY THE ORDER OF is the largest importer in Afghanistan with $135.6K USD in purchases. The top 3 suppliers — MEDYRA PHARMACEUTICAL, KWALITY PHARMACEUTICALS LIMITED, SARTAJ PHARMA PRIVATE LIMITED — together control 95% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Afghanistan Sorafenib corridor is one of India's established pharmaceutical export routes, with 19 shipments documented worth a combined $174.7K USD. The route is dominated by MEDYRA PHARMACEUTICAL, which alone accounts for roughly 80% of all export value, reflecting the consolidated nature of India's sorafenib manufacturing sector.
Across 8 active suppliers, the average shipment value stands at $9.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 23.2%, placing it at rank #5 among India's top sorafenib export destinations globally.
On the import side, key buyers of Indian sorafenib in Afghanistan include BY THE ORDER OF, TRUST ANESTHETIC LTD, SARTAJ ENTERPRIESES LIMITED and 8 others. BY THE ORDER OF is the single largest importer with 1 shipments valued at $135.6K USD.
